A carregar...
No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients
The discovery that BRAF is a driver oncogene in cancer, and complementary improvements in our understanding of the immune system have resulted in new targeted and immune‐therapies for metastatic melanoma. Targeted therapies achieve impressive clinical results in carefully selected patients but the d...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528622/ https://ncbi.nlm.nih.gov/pubmed/25178978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|